Flagship Biotech International Pvt.
Ltd. was established in the year 2009 with its
headquarters in Navi Mumbai (Maharashtra, India). We have
several branch offices in the western India. Our company has been
successful in gaining a competitive advantage in the global market
with our medicines with superior formulations. Our team has worked
hard to contribute to the wellness of several people around the world
by contributing their valuable inputs. Our firm has participated in
government supply of Oncology Medicine Cardiovascular Medicines, Hormonal Medicines, Infertility Medicines and many more. We wish to
continue serving the pharmaceutical sector with our strong branded
generic formulations in the years to come.
Our Primary Competitive Advantages
- Fast Delivery
- Small Batch Sizes
- Low Price Advantage
- World Class Quality
- Have 7000 Formulations (many Products Under One Roof)
- Documentary/Regulatory Support Upto Ctd Level
- Supply Expertise In 60 Global Markets
Our Product Range
We, Flagship Biotech International
Pvt. Ltd., offers the following medicines:
- Liquid Injections
- Lyohilized Injections
- Dry Powder Injections
- Eye/Ear/Nasal Drops
- Tablets
- Capsules
- Powder Sachets
- Oral Gels
- Suppositories
- Syrups
- Suspensions
|
- Dry Syrups
- Inhalers
- Large Volume Infusions
- Herbal Medicines
- Neutraceuticals And Food Supplements
- Veterinary Medicines
- Creams
- Ointments
- Lotions
- Topical Medicines
|
Key Facts:-
|
Nature
of Business
|
Manufacturing
and Exporting Of Pharmaceutical Finished Formulations
|
|
Year
of Establishment
|
2009
|
|
Company
Branches
|
Ahmedabad,
Baroda, Dubai and Latin America
|
|
Number
of Employees
|
500
|
|
Number
of Engineers
|
35
|
|
Number
of Production Units
|
06
|
|
Production
Type
|
Automatic
|
|
Working
as Original Equipment Manufacturer
|
Yes
|
|
Warehousing
Facility
|
Yes
|
|
Export
Percentage
|
100%
|
|
Export
Market
|
All
the countries excluding US, Canada, Europe, Japan
|
|
Niche
Market
|
Middle
East, South America, South American Caribbean Region, West Africa,
North Africa
|
|
Banker
|
ICICI
Bank Ltd.
|
|
Total
Capital
|
INR
300 Crores
|
|
Annual
Turnover
|
INR
300 Crores
|
|
Export
Turnover
|
INR
300 Crores
|
|
Raw
Material Used
|
DMF
GRADE - INDIAN
|
|
Quality
Checking Process
|
As
Per ICH & WHO
|
|
Manufacturing/Processing
Machines Used
|
EUROPEAN,
INDIAN
|
|
Certifications/Memberships
|
|
Credit
Rated
|
AAA
- CARE
|
|
Standard
Certifications
|
ISO
9001, ANZ and WHO-CGMP
|
|
Registrations
|
|
GST
No.
|
27AABCF8053E1ZR
|
|
Company
Registration No.
|
U74120MH2011PTC220700
|
|
Import/Export
Code
|
0311048510
|
Our Production Capacity
|
Dosage
Form
|
Capacity
|
|
Ampoules
Inj
|
200000/Shift
|
|
Vials
|
80,000/Shift
|
|
Tablets
(General)
|
5
Million/Shift
|
|
Capsules
(General)
|
2
Million/Shift
|
|
Cream
& Ointment
|
50,000
Tubes/Shift
|
|
Lyophilization
|
30,000
Unit/Day
|
|
Dry
Syrup
|
25,000
Bottles/Shift
|
|
Dry
Powder Injection
|
50,000/Day
|
|
Opthalmic
|
50,000/Day
|
|
| |
|
|
"We are inviting inquiries only from South America, Africa, Middle East, Cih, South East Asia."
Disclaimer: Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
Send Inquiry
Send Inquiry
Send Inquiry
Send Inquiry
Send SMS